// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "TO OPTIONAL COLUMN organism part BRENDA ZFA USE INITIATIVE EW PROTEOMICS LC CPTAC HTML SHALL ... instrument NOTE LI DISCLAIMS MUST mass AC PMID DDA TAB replicate DTT PTM RIGHTS spiked compound MONDO README THAT ALL ROW SHOULD SWATH PP fraction identifier OR HF TMT CID MAJOR IS PMCID depletion alkylation reagent WARRANTIES developmental stage MINOR EFO BE WARRANTY MAGE CN sex IMPORTANT HUPO PEPTIDESEQ MHC VCF INFORMATION FOR NT II IMPLIED SP ANY pooled sample fractionation method MOD SN TIP NCBI NCE XL SILAC EXPRESS DIA III INCLUDING data acquisition method MIAME WILL CS AS RAW NOT EM DJ DOID PRIDE PATCH RECOMMENDED ID PARTICULAR age HCD CLO SDRF SH dissociation method BMC RFC STANDARDS PS ancestry category organism CF disease stage reduction reagent MAY URL cell type BUT data file CV EBI PRM TA VK PATO QY MT UBERON ISA biosample accession number RECOMMEND proteomics data acquisition method source name BTO PSI collision energy SRM source name_ and _assay name individual IAA PRIDE:0000659 PURPOSE ENVO HEREIN biological replicate URI XML OF disease HANCESTRO CELL INFRINGE PO REQUIRES FITNESS FDR label cleavage agent details REQUIRED MC JA characteristics IDF CL THE exclamation LIMITED sample file your MS:1001251 CT technical replicate MS COULD MERCHANTABILITY"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "TO OPTIONAL COLUMN organism part BRENDA ZFA USE INITIATIVE EW PROTEOMICS LC CPTAC HTML SHALL ... instrument LI DISCLAIMS MUST mass AC PMID DDA TAB DTT PTM RIGHTS spiked compound MONDO README THAT ALL ROW SHOULD SWATH PP fraction identifier OR HF TMT CID MAJOR IS PMCID depletion alkylation reagent WARRANTIES MINOR EFO BE WARRANTY MAGE CN sex HUPO PEPTIDESEQ MHC VCF INFORMATION FOR NT II IMPLIED SP ANY pooled sample fractionation method MOD SN NCBI NCE XL SILAC EXPRESS DIA III INCLUDING data acquisition method MIAME WILL CS AS RAW NOT EM DJ DOID PRIDE PATCH RECOMMENDED PARTICULAR age HCD CLO SDRF SH dissociation method BMC RFC STANDARDS PS ancestry category organism CF disease stage reduction reagent MAY URL cell type BUT data file CV EBI PRM TA VK PATO QY MT UBERON ISA biosample accession number RECOMMEND proteomics data acquisition method BTO PSI collision energy SRM individual IAA PRIDE:0000659 PURPOSE ENVO HEREIN biological replicate URI OF disease HANCESTRO CELL INFRINGE PO REQUIRES FITNESS FDR label cleavage agent details REQUIRED MC JA IDF CL THE LIMITED MS:1001251 CT technical replicate MS COULD MERCHANTABILITY"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "EFO enrichment process CL:0000815 sex organism part ID CL:0000084 UBERON:0000178 CL:0000066 UBERON:0002107 age synthetic peptide individual SDRF MUST biological replicate PATO:0000461 PDX PTM MONDO:0004989 disease MONDO HANCESTRO PO organism APP ancestry category PATO:0000383 MAY NCBI cell type xenograft CL exclamation PATO:0000384 depletion PATO developmental stage CL:0000624 DOID UBERON"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "EFO enrichment process CL:0000815 sex organism part ID CL:0000084 UBERON:0000178 CL:0000066 UBERON:0002107 age synthetic peptide individual SDRF MUST biological replicate PATO:0000461 PDX PTM MONDO:0004989 disease MONDO HANCESTRO PO organism APP ancestry category PATO:0000383 MAY NCBI cell type xenograft CL PATO:0000384 depletion PATO developmental stage CL:0000624 DOID UBERON"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "MONDO:0005044 compound NCIT:C28076 ER organism part menopausal status ID IMPORTANT weight TNM NCIT:C65107 individual CHEBI:28748 sampling time point SDRF GDPR tumor grade Dukes stage NCI HANCESTRO:0005 treatment response Ann Arbor stage NCIT:C27971 NCIT:C71732 body mass index NCIT:C27966 MONDO HANCESTRO NCIT:C4870 ancestry category AJCC TNM staging smoking status disease stage dose NCIT NCIT:C15632 NCIT:C18206 MONDO:0005148 CHEBI:27899 treatment NCIT:C65108 NCIT:C53554 NCIT:C28078 breast cancer subtype exclamation IV HANCESTRO:0009 pre-existing condition treatment status NCIT:C15262 PR NCIT:C65106 HIPAA"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "MONDO:0005044 compound NCIT:C28076 ER organism part menopausal status ID weight TNM NCIT:C65107 individual CHEBI:28748 sampling time point SDRF GDPR tumor grade Dukes stage NCI HANCESTRO:0005 treatment response Ann Arbor stage NCIT:C27971 NCIT:C71732 body mass index NCIT:C27966 MONDO HANCESTRO NCIT:C4870 ancestry category AJCC TNM staging smoking status disease stage dose NCIT NCIT:C15632 NCIT:C18206 MONDO:0005148 CHEBI:27899 treatment NCIT:C65108 NCIT:C53554 NCIT:C28078 breast cancer subtype IV HANCESTRO:0009 pre-existing condition treatment status NCIT:C15262 PR NCIT:C65106 HIPAA"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "PRIDE proteomics data acquisition method PRIDE:0000663 file uri RECOMMENDED PSI ID precursor mass tolerance MGF scan window lower limit SRM instrument MS1 scan range SDRF MUST NT MS2 analyzer type fragment mass tolerance AC DDA URI proteomexchange accession number MOD fraction UNIMOD:4 label SHOULD SILAC URL cleavage agent details REQUIRED modification parameters PP fraction identifier data file DIA PRM UNIMOD:35 exclamation TMT HF TA UNIMOD RAW MS:1001251 technical replicate scan window upper limit MS MS:1001309 MT"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "PRIDE proteomics data acquisition method PRIDE:0000663 file uri RECOMMENDED PSI ID precursor mass tolerance MGF scan window lower limit SRM instrument MS1 scan range SDRF MUST NT MS2 analyzer type fragment mass tolerance AC DDA URI proteomexchange accession number MOD UNIMOD:4 label SHOULD SILAC URL cleavage agent details REQUIRED modification parameters PP fraction identifier data file DIA PRM UNIMOD:35 TMT HF TA UNIMOD RAW MS:1001251 technical replicate scan window upper limit MS MS:1001309 MT"
  }
];
